André Muller
Directeur Général chez IDORSIA LTD
Fortune : 236 174 $ au 30/06/2024
Profil
Mr. André C.
Muller is a Chief Executive Officer at Idorsia Ltd., a Chairman at Chiron Investments AG and a Director & General Manager at Idorsia Pharmaceuticals Ltd.
He is on the Board of Directors at Idorsia (Shanghai) Pharmaceuticals Co., Ltd., Idorsia Pharmaceuticals US, Inc. and Idorsia Pharmaceuticals Ltd.
Mr. Muller was previously employed as an Independent Director by Carmat SA, a Chief Financial Officer & Executive Vice President by Actelion Ltd., and a Chief Financial Officer by Pierre Fabre SA. He also served on the board at Nxera Pharma Japan Co., Ltd.
He received his MBA from EM Lyon Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IDORSIA LTD.
0,06% | 31/12/2023 | 104 751 ( 0,06% ) | 236 174 $ | 30/06/2024 |
Postes actifs de André Muller
| Sociétés | Poste | Début |
|---|---|---|
| IDORSIA LTD | Directeur Général | 13/06/2024 |
| Chiron Investments AG | Président | - |
| Idorsia Pharmaceuticals US, Inc. | Directeur/Membre du Conseil | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Directeur/Membre du Conseil | - |
| Idorsia (Shanghai) Pharmaceuticals Co., Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de André Muller
| Sociétés | Poste | Fin |
|---|---|---|
| CARMAT | Directeur/Membre du Conseil | 25/06/2024 |
| ACTELION | Directeur Financier/CFO | 01/01/2017 |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Directeur Financier/CFO | 01/01/2011 |
Idorsia Pharmaceuticals Japan Ltd.
 Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally. | Directeur/Membre du Conseil | - |
Formation de André Muller
| EM Lyon Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CARMAT | Health Technology |
| IDORSIA LTD | Health Technology |
| Entreprise privées | 7 |
|---|---|
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Health Technology |
| Idorsia Pharmaceuticals US, Inc. | |
| Idorsia (Shanghai) Pharmaceuticals Co., Ltd. | |
Idorsia Pharmaceuticals Japan Ltd.
Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally. | Health Technology |
| Chiron Investments AG |
